Cargando…
Overexpression of human kynurenine-3-monooxygenase protects against 3-hydroxykynurenine-mediated apoptosis through bidirectional nonlinear feedback
Kynurenine 3-monooxygenase (KMO) is a critical regulator of inflammation. The preferred KMO substrate, kynurenine, is converted to 3-hydroxykynurenine (3HK), and this product exhibits cytotoxicity through mechanisms that culminate in apoptosis. Here, we report that overexpression of human KMO with o...
Autores principales: | Wilson, K, Auer, M, Binnie, M, Zheng, X, Pham, N T, Iredale, J P, Webster, S P, Mole, D J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855666/ https://www.ncbi.nlm.nih.gov/pubmed/27077813 http://dx.doi.org/10.1038/cddis.2016.87 |
Ejemplares similares
-
Bacterial expression of human kynurenine 3-monooxygenase: Solubility, activity, purification()
por: Wilson, K., et al.
Publicado: (2014) -
Diclofenac Identified as a Kynurenine 3-Monooxygenase
Binder and Inhibitor by Molecular Similarity Techniques
por: Shave, Steven, et al.
Publicado: (2018) -
Kynurenine 3-monooxygenase is a critical regulator of renal ischemia–reperfusion injury
por: Zheng, Xiaozhong, et al.
Publicado: (2019) -
Increased levels of 3-hydroxykynurenine parallel disease severity in human acute pancreatitis
por: Skouras, Christos, et al.
Publicado: (2016) -
Kynurenine–3–monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis
por: Mole, Damian J, et al.
Publicado: (2016)